nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—ATIC—forebrain—attention deficit hyperactivity disorder	0.0148	0.0235	CbGeAlD
Methotrexate—FOLR1—central nervous system—attention deficit hyperactivity disorder	0.0137	0.0218	CbGeAlD
Methotrexate—FOLR1—cerebellum—attention deficit hyperactivity disorder	0.0134	0.0213	CbGeAlD
Methotrexate—ATIC—cardiovascular system—attention deficit hyperactivity disorder	0.0125	0.0199	CbGeAlD
Methotrexate—SLC19A1—nervous system—attention deficit hyperactivity disorder	0.0125	0.0198	CbGeAlD
Methotrexate—SLCO1C1—forebrain—attention deficit hyperactivity disorder	0.0123	0.0196	CbGeAlD
Methotrexate—SLC19A1—central nervous system—attention deficit hyperactivity disorder	0.012	0.0191	CbGeAlD
Methotrexate—SLC19A1—cerebellum—attention deficit hyperactivity disorder	0.0117	0.0187	CbGeAlD
Methotrexate—GGH—midbrain—attention deficit hyperactivity disorder	0.0115	0.0183	CbGeAlD
Methotrexate—MTHFR—forebrain—attention deficit hyperactivity disorder	0.011	0.0175	CbGeAlD
Methotrexate—FOLR1—brain—attention deficit hyperactivity disorder	0.0109	0.0173	CbGeAlD
Methotrexate—ATIC—midbrain—attention deficit hyperactivity disorder	0.00978	0.0155	CbGeAlD
Methotrexate—SLC46A1—nervous system—attention deficit hyperactivity disorder	0.00961	0.0153	CbGeAlD
Methotrexate—PGD—forebrain—attention deficit hyperactivity disorder	0.00956	0.0152	CbGeAlD
Methotrexate—SLC19A1—brain—attention deficit hyperactivity disorder	0.00954	0.0152	CbGeAlD
Methotrexate—GGH—nervous system—attention deficit hyperactivity disorder	0.00946	0.015	CbGeAlD
Methotrexate—MTHFR—cardiovascular system—attention deficit hyperactivity disorder	0.00931	0.0148	CbGeAlD
Methotrexate—SLC46A1—central nervous system—attention deficit hyperactivity disorder	0.00926	0.0147	CbGeAlD
Methotrexate—GGH—central nervous system—attention deficit hyperactivity disorder	0.00911	0.0145	CbGeAlD
Methotrexate—SLC46A1—cerebellum—attention deficit hyperactivity disorder	0.00905	0.0144	CbGeAlD
Methotrexate—GGH—cerebellum—attention deficit hyperactivity disorder	0.0089	0.0141	CbGeAlD
Methotrexate—DHFR—cardiovascular system—attention deficit hyperactivity disorder	0.00841	0.0134	CbGeAlD
Methotrexate—FPGS—nervous system—attention deficit hyperactivity disorder	0.00831	0.0132	CbGeAlD
Methotrexate—SLCO1C1—midbrain—attention deficit hyperactivity disorder	0.00813	0.0129	CbGeAlD
Methotrexate—PGD—cardiovascular system—attention deficit hyperactivity disorder	0.00809	0.0128	CbGeAlD
Methotrexate—ATIC—nervous system—attention deficit hyperactivity disorder	0.00804	0.0128	CbGeAlD
Methotrexate—FPGS—central nervous system—attention deficit hyperactivity disorder	0.00801	0.0127	CbGeAlD
Methotrexate—FPGS—cerebellum—attention deficit hyperactivity disorder	0.00782	0.0124	CbGeAlD
Methotrexate—ATIC—central nervous system—attention deficit hyperactivity disorder	0.00774	0.0123	CbGeAlD
Methotrexate—ATIC—cerebellum—attention deficit hyperactivity disorder	0.00757	0.012	CbGeAlD
Methotrexate—SLC16A1—cardiovascular system—attention deficit hyperactivity disorder	0.00755	0.012	CbGeAlD
Methotrexate—SLC46A1—brain—attention deficit hyperactivity disorder	0.00735	0.0117	CbGeAlD
Methotrexate—GGH—brain—attention deficit hyperactivity disorder	0.00723	0.0115	CbGeAlD
Methotrexate—SLCO3A1—midbrain—attention deficit hyperactivity disorder	0.00715	0.0114	CbGeAlD
Methotrexate—SLCO1A2—forebrain—attention deficit hyperactivity disorder	0.00707	0.0112	CbGeAlD
Methotrexate—ABCC4—forebrain—attention deficit hyperactivity disorder	0.0068	0.0108	CbGeAlD
Methotrexate—SLCO1C1—nervous system—attention deficit hyperactivity disorder	0.00669	0.0106	CbGeAlD
Methotrexate—TYMS—midbrain—attention deficit hyperactivity disorder	0.00663	0.0105	CbGeAlD
Methotrexate—DHFR—midbrain—attention deficit hyperactivity disorder	0.00657	0.0104	CbGeAlD
Methotrexate—SLCO1C1—central nervous system—attention deficit hyperactivity disorder	0.00644	0.0102	CbGeAlD
Methotrexate—FPGS—brain—attention deficit hyperactivity disorder	0.00636	0.0101	CbGeAlD
Methotrexate—PGD—midbrain—attention deficit hyperactivity disorder	0.00631	0.01	CbGeAlD
Methotrexate—ATIC—brain—attention deficit hyperactivity disorder	0.00615	0.00977	CbGeAlD
Methotrexate—MTHFR—nervous system—attention deficit hyperactivity disorder	0.00598	0.0095	CbGeAlD
Methotrexate—SLC16A1—midbrain—attention deficit hyperactivity disorder	0.0059	0.00937	CbGeAlD
Methotrexate—SLCO3A1—nervous system—attention deficit hyperactivity disorder	0.00588	0.00934	CbGeAlD
Methotrexate—MTHFR—central nervous system—attention deficit hyperactivity disorder	0.00575	0.00914	CbGeAlD
Methotrexate—SLCO3A1—central nervous system—attention deficit hyperactivity disorder	0.00566	0.009	CbGeAlD
Methotrexate—MTHFR—cerebellum—attention deficit hyperactivity disorder	0.00562	0.00894	CbGeAlD
Methotrexate—SLCO3A1—cerebellum—attention deficit hyperactivity disorder	0.00553	0.00879	CbGeAlD
Methotrexate—TYMS—nervous system—attention deficit hyperactivity disorder	0.00545	0.00867	CbGeAlD
Methotrexate—ABCC10—midbrain—attention deficit hyperactivity disorder	0.00541	0.0086	CbGeAlD
Methotrexate—DHFR—nervous system—attention deficit hyperactivity disorder	0.0054	0.00858	CbGeAlD
Methotrexate—TYMS—central nervous system—attention deficit hyperactivity disorder	0.00525	0.00834	CbGeAlD
Methotrexate—DHFR—central nervous system—attention deficit hyperactivity disorder	0.0052	0.00826	CbGeAlD
Methotrexate—PGD—nervous system—attention deficit hyperactivity disorder	0.00519	0.00825	CbGeAlD
Methotrexate—TYMS—cerebellum—attention deficit hyperactivity disorder	0.00513	0.00815	CbGeAlD
Methotrexate—SLCO1C1—brain—attention deficit hyperactivity disorder	0.00511	0.00812	CbGeAlD
Methotrexate—DHFR—cerebellum—attention deficit hyperactivity disorder	0.00508	0.00807	CbGeAlD
Methotrexate—PGD—central nervous system—attention deficit hyperactivity disorder	0.005	0.00794	CbGeAlD
Methotrexate—PGD—cerebellum—attention deficit hyperactivity disorder	0.00489	0.00776	CbGeAlD
Methotrexate—SLC16A1—nervous system—attention deficit hyperactivity disorder	0.00485	0.0077	CbGeAlD
Methotrexate—SLC22A7—brain—attention deficit hyperactivity disorder	0.00484	0.0077	CbGeAlD
Methotrexate—SLC22A6—brain—attention deficit hyperactivity disorder	0.00468	0.00743	CbGeAlD
Methotrexate—SLCO1A2—midbrain—attention deficit hyperactivity disorder	0.00467	0.00742	CbGeAlD
Methotrexate—SLC16A1—central nervous system—attention deficit hyperactivity disorder	0.00467	0.00741	CbGeAlD
Methotrexate—MTHFR—brain—attention deficit hyperactivity disorder	0.00457	0.00726	CbGeAlD
Methotrexate—SLC16A1—cerebellum—attention deficit hyperactivity disorder	0.00456	0.00725	CbGeAlD
Methotrexate—SLCO3A1—brain—attention deficit hyperactivity disorder	0.0045	0.00714	CbGeAlD
Methotrexate—ABCC3—nervous system—attention deficit hyperactivity disorder	0.00447	0.00711	CbGeAlD
Methotrexate—ABCC3—central nervous system—attention deficit hyperactivity disorder	0.00431	0.00684	CbGeAlD
Methotrexate—AOX1—cerebellum—attention deficit hyperactivity disorder	0.0043	0.00684	CbGeAlD
Methotrexate—ABCC10—cerebellum—attention deficit hyperactivity disorder	0.00419	0.00666	CbGeAlD
Methotrexate—TYMS—brain—attention deficit hyperactivity disorder	0.00417	0.00662	CbGeAlD
Methotrexate—DHFR—brain—attention deficit hyperactivity disorder	0.00413	0.00656	CbGeAlD
Methotrexate—PGD—brain—attention deficit hyperactivity disorder	0.00397	0.0063	CbGeAlD
Methotrexate—SLCO1A2—nervous system—attention deficit hyperactivity disorder	0.00384	0.0061	CbGeAlD
Methotrexate—SLC16A1—brain—attention deficit hyperactivity disorder	0.0037	0.00589	CbGeAlD
Methotrexate—SLCO1A2—central nervous system—attention deficit hyperactivity disorder	0.00369	0.00587	CbGeAlD
Methotrexate—ABCC4—nervous system—attention deficit hyperactivity disorder	0.00369	0.00587	CbGeAlD
Methotrexate—SLC22A8—nervous system—attention deficit hyperactivity disorder	0.00366	0.00582	CbGeAlD
Methotrexate—SLCO1A2—cerebellum—attention deficit hyperactivity disorder	0.00361	0.00574	CbGeAlD
Methotrexate—ABCC4—central nervous system—attention deficit hyperactivity disorder	0.00356	0.00565	CbGeAlD
Methotrexate—SLC22A8—central nervous system—attention deficit hyperactivity disorder	0.00353	0.0056	CbGeAlD
Methotrexate—AOX1—brain—attention deficit hyperactivity disorder	0.0035	0.00555	CbGeAlD
Methotrexate—ABCC3—brain—attention deficit hyperactivity disorder	0.00342	0.00543	CbGeAlD
Methotrexate—ABCC10—brain—attention deficit hyperactivity disorder	0.0034	0.00541	CbGeAlD
Methotrexate—ABCG2—midbrain—attention deficit hyperactivity disorder	0.00317	0.00504	CbGeAlD
Methotrexate—ABCC1—cerebellum—attention deficit hyperactivity disorder	0.00296	0.00471	CbGeAlD
Methotrexate—SLCO1A2—brain—attention deficit hyperactivity disorder	0.00293	0.00466	CbGeAlD
Methotrexate—ALB—brain—attention deficit hyperactivity disorder	0.00292	0.00463	CbGeAlD
Methotrexate—ABCC4—brain—attention deficit hyperactivity disorder	0.00282	0.00448	CbGeAlD
Methotrexate—SLC22A8—brain—attention deficit hyperactivity disorder	0.0028	0.00445	CbGeAlD
Methotrexate—ABCG2—cerebellum—attention deficit hyperactivity disorder	0.00245	0.0039	CbGeAlD
Methotrexate—ABCC1—brain—attention deficit hyperactivity disorder	0.00241	0.00382	CbGeAlD
Methotrexate—ABCB1—forebrain—attention deficit hyperactivity disorder	0.00237	0.00376	CbGeAlD
Methotrexate—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.002	0.00318	CbGeAlD
Methotrexate—ABCG2—brain—attention deficit hyperactivity disorder	0.00199	0.00317	CbGeAlD
Methotrexate—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00156	0.00248	CbGeAlD
Methotrexate—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00129	0.00204	CbGeAlD
Methotrexate—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.00124	0.00197	CbGeAlD
Methotrexate—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.00121	0.00192	CbGeAlD
Methotrexate—ABCB1—brain—attention deficit hyperactivity disorder	0.000982	0.00156	CbGeAlD
Methotrexate—PGD—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000881	0.00238	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000879	0.00237	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.000865	0.00233	CbGpPWpGaD
Methotrexate—SLCO1B3—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000855	0.00231	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000854	0.0023	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000854	0.0023	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000854	0.0023	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000854	0.0023	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000852	0.0023	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000842	0.00227	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00084	0.00227	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00084	0.00227	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000839	0.00226	CbGpPWpGaD
Methotrexate—FPGS—Disease—SNAP25—attention deficit hyperactivity disorder	0.000815	0.0022	CbGpPWpGaD
Methotrexate—MTHFR—Disease—STUB1—attention deficit hyperactivity disorder	0.000808	0.00218	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000803	0.00217	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.0008	0.00216	CbGpPWpGaD
Methotrexate—AOX1—Disease—STUB1—attention deficit hyperactivity disorder	0.000789	0.00213	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000781	0.00211	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000781	0.00211	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000776	0.00209	CbGpPWpGaD
Methotrexate—SLCO1C1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000767	0.00207	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000764	0.00206	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—ADRA2C—attention deficit hyperactivity disorder	0.00076	0.00205	CbGpPWpGaD
Methotrexate—SLC22A8—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000756	0.00204	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000741	0.002	CbGpPWpGaD
Methotrexate—DHFR—Disease—STUB1—attention deficit hyperactivity disorder	0.000718	0.00194	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000682	0.00184	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000682	0.00184	CbGpPWpGaD
Methotrexate—SLCO1A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000671	0.00181	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000665	0.00179	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000665	0.00179	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000654	0.00177	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00065	0.00175	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00065	0.00175	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—SNAP25—attention deficit hyperactivity disorder	0.000635	0.00171	CbGpPWpGaD
Methotrexate—SLC22A6—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000631	0.0017	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.00061	0.00164	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000608	0.00164	CbGpPWpGaD
Methotrexate—PGD—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000608	0.00164	CbGpPWpGaD
Methotrexate—PGD—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000608	0.00164	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000608	0.00164	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000604	0.00163	CbGpPWpGaD
Methotrexate—PGD—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000598	0.00161	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000581	0.00157	CbGpPWpGaD
Methotrexate—PGD—Disease—SNAP25—attention deficit hyperactivity disorder	0.000581	0.00157	CbGpPWpGaD
Methotrexate—ABCG2—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000581	0.00157	CbGpPWpGaD
Methotrexate—SLCO1B1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000574	0.00155	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000568	0.00153	CbGpPWpGaD
Methotrexate—PGD—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000556	0.0015	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000532	0.00143	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—COMT—attention deficit hyperactivity disorder	0.000517	0.0014	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—COMT—attention deficit hyperactivity disorder	0.000517	0.0014	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000517	0.00139	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000514	0.00139	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000514	0.00139	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000506	0.00137	CbGpPWpGaD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000504	0.00136	CbGpPWpGaD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000494	0.00133	CbGpPWpGaD
Methotrexate—PGD—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000486	0.00131	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000479	0.00129	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000471	0.00127	CbGpPWpGaD
Methotrexate—PGD—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000463	0.00125	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000457	0.00123	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000457	0.00123	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000455	0.00123	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000451	0.00122	CbGpPWpGaD
Methotrexate—TYMS—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000435	0.00117	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000434	0.00117	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00042	0.00113	CbGpPWpGaD
Methotrexate—TYMS—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000417	0.00113	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000414	0.00112	CbGpPWpGaD
Methotrexate—ABCC1—Disease—STUB1—attention deficit hyperactivity disorder	0.000406	0.0011	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000403	0.00109	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000401	0.00108	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000401	0.00108	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.0004	0.00108	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.0004	0.00108	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	0.000399	0.00108	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000395	0.00107	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000392	0.00106	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000392	0.00106	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000392	0.00106	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.000392	0.00106	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000386	0.00104	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000384	0.00104	CbGpPWpGaD
Methotrexate—MTHFR—Disease—SNAP25—attention deficit hyperactivity disorder	0.000383	0.00103	CbGpPWpGaD
Methotrexate—AOX1—Disease—SNAP25—attention deficit hyperactivity disorder	0.000374	0.00101	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000373	0.00101	CbGpPWpGaD
Methotrexate—PGD—Metabolism—COMT—attention deficit hyperactivity disorder	0.000369	0.000994	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000368	0.000994	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000367	0.00099	CbGpPWpGaD
Methotrexate—PGD—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000366	0.000987	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000359	0.000967	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000357	0.000962	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000357	0.000962	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000351	0.000947	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000341	0.000921	CbGpPWpGaD
Methotrexate—DHFR—Disease—SNAP25—attention deficit hyperactivity disorder	0.00034	0.000918	CbGpPWpGaD
Methotrexate—ALB—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000328	0.000885	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000326	0.00088	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000325	0.000877	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000325	0.000876	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000325	0.000876	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000321	0.000866	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000321	0.000865	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00032	0.000862	CbGpPWpGaD
Methotrexate—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.000314	0.000847	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000313	0.000845	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—EP300—attention deficit hyperactivity disorder	0.000311	0.00084	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000311	0.00084	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000311	0.00084	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000311	0.000838	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000307	0.000828	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000306	0.000826	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000305	0.000824	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.0003	0.000809	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000298	0.000805	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000297	0.000801	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000292	0.000789	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000292	0.000787	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000285	0.00077	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000285	0.00077	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000285	0.000769	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000285	0.000768	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000281	0.000758	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000278	0.00075	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000271	0.000732	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00027	0.000729	CbGpPWpGaD
Methotrexate—FPGS—Disease—EP300—attention deficit hyperactivity disorder	0.000265	0.000715	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000261	0.000704	CbGpPWpGaD
Methotrexate—SLC19A1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000261	0.000704	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00026	0.000701	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000258	0.000695	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000258	0.000695	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000257	0.000694	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000253	0.000684	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000249	0.000671	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000247	0.000667	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—COMT—attention deficit hyperactivity disorder	0.000243	0.000656	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000241	0.000651	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle, Mitotic—EP300—attention deficit hyperactivity disorder	0.000241	0.000651	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000237	0.000641	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000237	0.000639	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000236	0.000636	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000236	0.000636	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000228	0.000616	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000224	0.000605	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000224	0.000605	CbGpPWpGaD
Methotrexate—ATIC—Metabolism—EP300—attention deficit hyperactivity disorder	0.000222	0.000598	CbGpPWpGaD
Methotrexate—FPGS—Metabolism—EP300—attention deficit hyperactivity disorder	0.000222	0.000598	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000221	0.000595	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000217	0.000586	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—COMT—attention deficit hyperactivity disorder	0.000216	0.000583	CbGpPWpGaD
Methotrexate—DHFR—Cell Cycle—EP300—attention deficit hyperactivity disorder	0.000216	0.000582	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000215	0.000579	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle, Mitotic—EP300—attention deficit hyperactivity disorder	0.00021	0.000568	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000208	0.000562	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—EP300—attention deficit hyperactivity disorder	0.000206	0.000557	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000206	0.000556	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.000206	0.000555	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000205	0.000553	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000202	0.000545	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000202	0.000545	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000199	0.000536	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000197	0.000531	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000196	0.000529	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000195	0.000527	CbGpPWpGaD
Methotrexate—ABCC1—Disease—SNAP25—attention deficit hyperactivity disorder	0.000193	0.00052	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000192	0.000517	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000192	0.000517	CbGpPWpGaD
Methotrexate—PGD—Disease—EP300—attention deficit hyperactivity disorder	0.000189	0.000509	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000189	0.000509	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—COMT—attention deficit hyperactivity disorder	0.000189	0.000509	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle—EP300—attention deficit hyperactivity disorder	0.000188	0.000508	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000187	0.000505	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000185	0.000498	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000179	0.000484	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000178	0.000479	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000178	0.000479	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000175	0.000473	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000175	0.000471	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000173	0.000467	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000173	0.000466	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000172	0.000463	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000171	0.000461	CbGpPWpGaD
Methotrexate—ALB—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000167	0.00045	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000167	0.000449	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000162	0.000438	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000161	0.000435	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000159	0.000428	CbGpPWpGaD
Methotrexate—PGD—Metabolism—EP300—attention deficit hyperactivity disorder	0.000158	0.000426	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000156	0.000421	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000155	0.000419	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000155	0.000418	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000154	0.000414	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000153	0.000414	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.00015	0.000405	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000146	0.000394	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000146	0.000394	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000142	0.000383	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000139	0.000375	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000136	0.000367	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000135	0.000365	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000135	0.000364	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000134	0.000362	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000131	0.000353	CbGpPWpGaD
Methotrexate—MTHFR—Disease—EP300—attention deficit hyperactivity disorder	0.000125	0.000336	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000122	0.00033	CbGpPWpGaD
Methotrexate—AOX1—Disease—EP300—attention deficit hyperactivity disorder	0.000122	0.000328	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000121	0.000328	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000118	0.000318	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000116	0.000314	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000115	0.000311	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000112	0.000302	CbGpPWpGaD
Methotrexate—DHFR—Disease—EP300—attention deficit hyperactivity disorder	0.000111	0.000299	CbGpPWpGaD
Methotrexate—ALB—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00011	0.000296	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00011	0.000296	CbGpPWpGaD
Methotrexate—ALB—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000108	0.000291	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000108	0.00029	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000107	0.000288	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—EP300—attention deficit hyperactivity disorder	0.000104	0.000281	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000102	0.000275	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.0001	0.00027	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	9.6e-05	0.000259	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	9.6e-05	0.000259	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	9.45e-05	0.000255	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—EP300—attention deficit hyperactivity disorder	9.27e-05	0.00025	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.78e-05	0.000237	CbGpPWpGaD
Methotrexate—ALB—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.76e-05	0.000236	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—EP300—attention deficit hyperactivity disorder	8.44e-05	0.000228	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ADRA2A—attention deficit hyperactivity disorder	8.34e-05	0.000225	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—EP300—attention deficit hyperactivity disorder	8.08e-05	0.000218	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.68e-05	0.000207	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—EP300—attention deficit hyperactivity disorder	7.42e-05	0.0002	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.31e-05	0.000197	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—EP300—attention deficit hyperactivity disorder	7.02e-05	0.000189	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—EP300—attention deficit hyperactivity disorder	6.69e-05	0.000181	CbGpPWpGaD
Methotrexate—ALB—Metabolism—COMT—attention deficit hyperactivity disorder	6.64e-05	0.000179	CbGpPWpGaD
Methotrexate—ALB—Metabolism—MAOA—attention deficit hyperactivity disorder	6.59e-05	0.000178	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	6.39e-05	0.000172	CbGpPWpGaD
Methotrexate—ABCC1—Disease—EP300—attention deficit hyperactivity disorder	6.26e-05	0.000169	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—EP300—attention deficit hyperactivity disorder	5.83e-05	0.000157	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	5.82e-05	0.000157	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	5.78e-05	0.000156	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—EP300—attention deficit hyperactivity disorder	5.24e-05	0.000141	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—EP300—attention deficit hyperactivity disorder	4.98e-05	0.000134	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—EP300—attention deficit hyperactivity disorder	4.61e-05	0.000124	CbGpPWpGaD
Methotrexate—ALB—Metabolism—EP300—attention deficit hyperactivity disorder	2.85e-05	7.68e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	2.49e-05	6.73e-05	CbGpPWpGaD
